Our Gilead stock price prediction shows gains ahead, even after Gilead Sciences Inc. (Nasdaq: GILD) shares have fallen more than 7% since the...
Sometimes Washington triggers a stock move that can hand us outsized gains. That's exactly what happened with Gilead Sciences Inc. (Nasdaq: GILD)....
While others get distracted by the noise on Wall Street, we're staying focused on our long-term objective of building wealth through tech...
Today we're taking a look at four of your most perceptive investing questions. We also answer an inquiry from Stuart Varney.
After all,...
Gilead Sciences Inc. (Nasdaq: GILD) is facing criticism again this week for its highly priced Hepatitis C drug Sovaldi. The...
Dividend Investing News, Feb. 9, 2015: Stocks that sport attractive and growing dividends are still the best option...
Our 2015 stock picks show us two trends.
Precious metals are still surging. And now, biotech stocks are coming into 2015...
Today I want to reintroduce you to a biotech stock that Wall Street has been pricing as though it were dead money.
This biotech company...
In my 30 years knocking around Silicon Valley, I've found that the stocks with the best charts tend to be small caps.
But my charts...
One of the reasons biotech stocks can be your portfolio’s biggest winners is because of the massive profits companies see after releasing a...
Since April 11, Gilead Sciences (Nasdaq: GILD) has scored peak gains of a 74.2% - or more than 175% annualized...
Gilead Sciences Inc. (Nasdaq: GILD) stock hit a 52-week high of $92.97 this morning (Thursday) after the company crushed...
